Parallel announced that we intend to become a publicly traded company on the Canadian NEO exchange through a business combination with Ceres Acquisition Corp., a special purpose acquisition corporation (SPAC). This milestone achievement reflects Parallel’s maturity as an organization, proven business model and strong balance sheet — all of which stems from our mission to pioneer well-being and improve the quality of life through cannabinoids.
Date: February 22, 2021
Time: 9:00am EST
Conference Call Details:
Toll Free (U.S.): (855)-480-0897
Toll Free (International): (469)-565-9982
Conference ID: 4779728